30 results on '"Kasymjanova G"'
Search Results
2. A comparison of the effects of medical Qigong and standard exercise therapy on symptoms and quality of life in patients with advanced cancer
3. Validation of Known Radiomics Biomarkers for Post-Treatment Local Response for SBRT-Treated NSCLC, Using Machine Learning.
4. P3.06D.08 ctDNA-NGS Assay (Liquid Biopsy) for Non-Small Cell Lung Cancer: Utility of Plasma Cell-Free DNA and Tissue NGS in Detecting Genetic Mutations.
5. Understanding clinical practice and survival outcomes in patients with unresectable stage III non-small-cell lung cancer in a single centre in Quebec.
6. EP12.03-02 Previously Treated Advanced-Disease NSCLC KRAS G12C From a Canadian Multi-Institutional Real-World Evidence Database (CARMA).
7. Does the presence of emphysema increase the risk of radiation pneumonitis in lung cancer patients?
8. EP06.01-001 The Longitudinal Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Centre: A Retrospective Chart Review.
9. EP04.02-004 The Patient Impact of Liquid Biopsy - Health-Related Quality of Life in Patients Undergoing Liquid Biopsy for Advanced Non-Small Cell Lung Cancer.
10. Lung cancer care trajectory at a Canadian centre: an evaluation of how wait times affect clinical outcomes.
11. EP11.03-001 Loss of SUSD2 Expression in Lung Adenocarcinoma Correlates with Solid Pattern, Higher Histological Grading and Higher Ki-67 Cycling Index.
12. An exploratory comparative analysis of tyrosine kinase inhibitors or docetaxel in second-line treatment of EGFR wild-type non-small-cell lung cancer: a retrospective real-world practice review at a single tertiary care centre.
13. Montreal prognostic score: estimating survival of patients with non-small cell lung cancer using clinical biomarkers.
14. The potential role for acupuncture in treating symptoms in patients with lung cancer: an observational longitudinal study.
15. Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer.
16. Prevalence of emotional distress in newly diagnosed lung cancer patients.
17. Characteristics and outcomes of medulloblastoma in adults.
18. P31.01 Impact of COVID-19 on Lung Cancer Diagnosis and Treatment: A Retrospective Chart Review.
19. P24.11 Cell-Free Tumor DNA (ctDNA) Utility in Detection and Monitoring EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC).
20. P2.09-07 Does Metastatic Site Matter for PD-L1 Testing in Stage IV NSCLC?
21. P1.04-16 Comparison of Clinical Response to Checkpoint Inhibitors in Advanced NSCLC with High PD-L1 Expression Tested on Cytology Versus Biopsy Samples.
22. MA21.09 Differential Gene Expression in Tumor and Normal Tissue Reveals New Insights in the Biology of Non-Small Cell Lung Carcinoma.
23. MA09.09 EBUS-TBNA in Assessing PD-L1 Expression in NSCLC.
24. P2.01-04 Reducing Time to Molecular Diagnosis for Advanced NSCLC in the Context of a Reference Testing Center.
25. The metastatic site does not influence PD-L1 expression in advanced non-small cell lung carcinoma.
26. 6590 POSTER Influence of baseline inflammatory markers on the response to first-line chemotherapy in advanced NSCLC.
27. 1798P Relapsed and refractory systemic therapy real-world outcomes in the Canadian small cell lung cancer database (CASCADE).
28. Erratum to "The metastatic site does not influence PD-L1 expression in advanced non-small cell lung carcinoma" [Lung Cancer 132 (June) (2019) 36–38].
29. 1425P Clinical utility of liquid biopsy for the early diagnosis of EGFR mutant advanced lung cancer in real-life setting (CLEAR).
30. Does the Breast Cancer Molecular Subtype Affect the Post-Radiation Therapy Pattern of Recurrence?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.